CVS Health Corp (CVS) Receives $75.79 Consensus Target Price from Analysts

Shares of CVS Health Corp (NYSE:CVS) have been given an average recommendation of “Buy” by the twenty-six brokerages that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, fourteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $75.79.

A number of research analysts recently issued reports on CVS shares. ValuEngine lowered shares of CVS Health from a “sell” rating to a “strong sell” rating in a report on Thursday, February 28th. CIBC reiterated a “market perform” rating on shares of CVS Health in a report on Monday, April 15th. Oppenheimer lowered shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Monday, April 15th. Argus dropped their price objective on shares of CVS Health from $100.00 to $80.00 and set a “positive” rating for the company in a report on Monday, February 25th. Finally, SunTrust Banks dropped their price objective on shares of CVS Health to $85.00 and set a “buy” rating for the company in a report on Thursday, February 21st.

NYSE CVS traded up $0.58 during trading hours on Thursday, reaching $52.88. The company’s stock had a trading volume of 8,046,588 shares, compared to its average volume of 10,949,450. The firm has a market cap of $68.70 billion, a PE ratio of 7.47, a price-to-earnings-growth ratio of 1.03 and a beta of 0.93. CVS Health has a 52 week low of $51.72 and a 52 week high of $82.15. The company has a debt-to-equity ratio of 1.45, a current ratio of 0.95 and a quick ratio of 0.64.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.12. The business had revenue of $61.65 billion during the quarter, compared to analyst estimates of $60.39 billion. CVS Health had a negative net margin of 0.08% and a positive return on equity of 16.80%. The firm’s quarterly revenue was up 34.8% on a year-over-year basis. During the same quarter last year, the business earned $1.48 EPS. As a group, research analysts anticipate that CVS Health will post 6.83 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, May 3rd. Shareholders of record on Tuesday, April 23rd were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, April 22nd. This represents a $2.00 annualized dividend and a yield of 3.78%. CVS Health’s payout ratio is 28.25%.

In related news, Director C David Brown II acquired 10,000 shares of CVS Health stock in a transaction dated Monday, March 11th. The stock was bought at an average price of $53.18 per share, with a total value of $531,800.00. Following the transaction, the director now directly owns 16,222 shares in the company, valued at approximately $862,685.96. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Edward J. Ludwig acquired 4,000 shares of CVS Health stock in a transaction dated Friday, March 1st. The shares were bought at an average cost of $58.27 per share, with a total value of $233,080.00. Following the transaction, the director now owns 5,378 shares in the company, valued at $313,376.06. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 23,600 shares of company stock valued at $1,270,896. Company insiders own 0.53% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Bell Rock Capital LLC boosted its holdings in CVS Health by 764.0% during the 4th quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 382 shares during the last quarter. Riggs Asset Managment Co. Inc. boosted its holdings in CVS Health by 58.1% during the 1st quarter. Riggs Asset Managment Co. Inc. now owns 544 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 200 shares during the last quarter. Daiwa SB Investments Ltd. purchased a new position in CVS Health during the 4th quarter worth $30,000. Bay Harbor Wealth Management LLC boosted its holdings in CVS Health by 1,871.4% during the 1st quarter. Bay Harbor Wealth Management LLC now owns 552 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 524 shares during the last quarter. Finally, Acima Private Wealth LLC purchased a new position in CVS Health during the 4th quarter worth $33,000. 80.39% of the stock is owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Why are percentage decliners important?

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.